Publications
-
HIV/AIDS: Measuring an Evolving Virus
Humble M,
Pilkinton M, McGlynn L.
Journal of Human Behavior in the Social Environment,.
2011;
21
(4):
398:409
-
A pilot study investigating the effects of trauma, experiential avoidance, and disease management in HIV-positive MSM using methamphetamine.
Chartier M,
Vinatieri T, Delonga K, McGlynn LM, Gore-Felton C, Koopman C.
J Int Assoc Physicians AIDS Care (Chic).
2010 Mar-Apr;
9
(2):
78-81
-
Personal values and meaning in the use of methamphetamine among HIV-positive men who have sex with men.
Chartier M,
Araneta A, Duca L, McGlynn LM, Gore-Felton C, Goldblum P, Koopman C.
Qual Health Res.
2009;
19
(4):
504-18
-
Psychopharmacology and the HIV Positive Patient
McGlynn LM,
Marcus PH.
American Society of Clinical Psychopharmacology Model Psychopharmacology Curriculum (ASCP) for Training Directors and Teachers of Psychopharmacology in Psychiatric Residency Programs.
2009
5
-
HIV-associated cognitive impairment: key issues for providers.
McGlynn L,
Chartier M.
Focus.
2008;
23
(3):
5-8
-
Impact of Pneumocystis carinii and cytomegalovirus on the course and outcome of atypical pneumonia in advanced human immunodeficiency virus disease.
Bozzette SA,
Arcia J, Bartok AE, McGlynn LM, McCutchan JA, Richman DD, Spector SA.
J Infect Dis.
1992;
165
(1):
93-8
-
The impact of concomitant viral pathogens on the course of Pneumocystis carinii pneumonia.
Bozzette SA,
Arcia J, Bartok AE, McGlynn LM, McCutchan JA, Richman DD, Spragg R, Spector SA.
J Protozool.
1991 Nov-Dec;
38
(6):
183S-184S
Help